Skip to main content

Methylphenidate

From The New York Times:
Panel Recommends Warnings for Ritalin and Other Stimulants
By THE ASSOCIATED PRESS
Published: February 9, 2006
Filed at 4:13 p.m. ET

WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious type of warning labels for Ritalin and other stimulants that are used to treat attention deficit hyperactivity disorder.

The 8-7 vote, with one abstention, by the Food and Drug Administration committee was to recommend adding ''black box'' safety warnings to ADHD drugs. Doctors prescribe the increasingly popular drugs to about 2 million children and 1 million adults a month.

The FDA isn't required to follow the recommendations of its advisory committees but typically does.

[...continues...]
[ ... Read the full article ... ]
-
Anthony H. Risser | |

Comments

Post a Comment

Popular posts from this blog

Post a Comment
Read more

Welcome to Fall Semester!

Post a Comment
Read more

#INS2019inNYC (Entry 3)

I have two favorite parts of any INS conference: The agora of poster sessions and The Birch Lecture (named for Herbert Birch). The Benton and - now - the Satz Awards are nostalgic reminders. Finally, Plenary C looks interesting: "Generation of New Hippocampal Neurons in the Adult Brain: Implications for Mental Health", as does Invited Symposium 3: "Global Neuroscience: Impact of Culture, Resources, and Education". I have always tracked the The Birch Lecture. Herbert G. Birch was, from all accounts, a wonderful person and an extraordinary teacher. When I was an undergraduate student, I received mentoring in developmental biopsychology from several of his colleagues and students (Susan Fleischer, Tina Moreau, and Gerald Turkewitz). I worked as a student with rat models of perinatal malnutrition, which was a methodological offshoot of his long interest in malnutrition and poverty. My MA thesis was based on his groundbreaking work exploring neonatal lateralization. He...
Post a Comment
Read more